OBJECTIVE To develop a method for the determination of zaleplon in its pharmaceutical material and preparation METHODS A RP-HPLC method was used with Waters Spherisorb S5 ODS2 (5μm, 4.6 mm×250 mm) column. The mobile phase was a mixture of methanol -0.01 mol·L-1 phosphoric acid (57∶43) and the flow rate was 1.0 mL·min-1, and column temperature 25℃, with the detection wavelength at 231 nm RESULTS The precision and stability were fine. The linear correlation was observed from the concentrations of 0.011 3 mg·mL-1 to 0.067 5 mg·mL-1 (r=0.999 8). The average recovery was 99.7%. Resolution between zaleplon peak and other peaks met the requirements CONCLUSION The method was convenient, selective and reproducible.
Key words
zaleplon /
HPLC
{{custom_keyword}} /
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1]Caudreault J, Varin F, Pollack GM. Pharmacokinetics and anticonvulsant effect of a new hypnotic, CL 284, 846 in rats[J].Pharmacol Res Commun, 1995,12(11):1592.
[2]Askamoto T, Uchimura N, Mukai M,et al. Efficacy of L846 in patients with insomnia: evaluation by polysomnography[J].Psychiatry Clin Neurosci, 1998,52(2):156.
[3]胡晓敏.扎来普隆的研究进展[J]. 中国临床药理学杂志,2000,16(6):445.
{{custom_fnGroup.title_en}}
Footnotes
{{custom_fn.content}}